AbbVie Buys Phase II MDD Candidate From Gilgamesh, But Not The Company

 
• By Joseph Haas
  
AbbVie adds to its neuro pipeline in asset-purchase agreement with Gilgamesh • Source: Shutterstock

More from Deals

More from Business